Form 4: Avantor Executive Brittany Hankamer Reports Stock and Option Grants

Brittany Hankamer, EVP and Chief HR Officer of Avantor, Inc., reports the acquisition of restricted stock units and stock options.

Summary

• Brittany Hankamer, an executive at Avantor, Inc., filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
• On February 23, 2024, Hankamer acquired 11,293 shares of common stock at $0, resulting in a total of 34,966 shares beneficially owned.
• Hankamer was also granted 27,612 stock options with an exercise price of $24.35, exercisable beginning February 23, 2025, and expiring on February 23, 2034.
• Additionally, she received restricted stock units for 11,293 shares, vesting in three equal annual installments starting February 23, 2025.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, indicating a stable and well-managed company. The grants suggest confidence in future performance.

Positives

• The grant of stock options and restricted stock units aligns Hankamer's interests with those of Avantor's shareholders, incentivizing her to contribute to the company's long-term success.
• The vesting schedules for both the stock options and restricted stock units encourage continued service and commitment from Hankamer.

Future Outlook

The document does not contain specific forward-looking statements about Avantor's future performance, but the equity grants suggest an expectation of continued growth and value creation.

Industry Context

Equity grants are a common practice in the life sciences and healthcare industries to attract, retain, and incentivize key executives. These grants align executive compensation with shareholder value and company performance.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are standard compensation components for executives in publicly traded companies, particularly in the life sciences and healthcare sectors.
• Companies like Thermo Fisher Scientific and Danaher also utilize similar equity-based compensation plans to incentivize their executives.
• The vesting schedules (three-year annual installments) are typical for these types of grants, aligning with industry norms for retention and performance incentives.

Stakeholder Impact

• Shareholders may view the equity grants positively, as they align executive interests with long-term value creation.
• Employees may see the grants as a sign of the company's commitment to its leadership team.

Key Dates